Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Mangoni

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 11, 2022
Radiobiology of stereotactic radiotherapyMonica Mangoni, Simona Borghesi, Cynthia Aristei, et al.
Clinical & Experimental Metastasis|January 20, 2021
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literatureGiulio Francolini, Mauro Loi, Beatrice Detti, et al.
Cancer Medicine|March 25, 2018
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapyGiulia Lori, Paolo Paoli, Anna Caselli, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2010
Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patientsMonica Mangoni, Simonetta Bisanzi, Francesca Carozzi, et al.
Tumori|December 14, 2012
Stem cell tracking: toward clinical application in oncology?Monica Mangoni, Lorenzo Livi, Giampaolo Biti, et al.
Clinical and Translational Radiation Oncology|May 22, 2020
Biomarkers in wound drainage fluids of head and neck squamous cell carcinoma patients receiving neck dissection: A pilot studyTommaso Gualtieri, Pierluigi Bonomo, Mariangela Sottili, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)Pierluigi Bonomo, Isacco Desideri, Mauro Loi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 9, 2025
Fluorescent Deferoxamine Complexes of Cu(II) and Zr(IV): Insights in the Development of Dual Imaging ProbesAndrea Bencini, Yschtar Tecla Simonini Steiner, Virginia Zizi, et al.
Clinical & Experimental Metastasis|October 15, 2022
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancerGiulio Francolini, Vanessa Di Cataldo, Beatrice Detti, et al.
Tumori|February 8, 2013
From a waiting list to a priority list: a computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for radiotherapySilvia Scoccianti, Benedetta Agresti, Gabriele Simontacchi, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 11, 2022
Radiobiology of stereotactic radiotherapyMonica Mangoni, Simona Borghesi, Cynthia Aristei, et al.
Clinical & Experimental Metastasis|January 20, 2021
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literatureGiulio Francolini, Mauro Loi, Beatrice Detti, et al.
Cancer Medicine|March 25, 2018
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapyGiulia Lori, Paolo Paoli, Anna Caselli, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2010
Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patientsMonica Mangoni, Simonetta Bisanzi, Francesca Carozzi, et al.
Tumori|December 14, 2012
Stem cell tracking: toward clinical application in oncology?Monica Mangoni, Lorenzo Livi, Giampaolo Biti, et al.
Clinical and Translational Radiation Oncology|May 22, 2020
Biomarkers in wound drainage fluids of head and neck squamous cell carcinoma patients receiving neck dissection: A pilot studyTommaso Gualtieri, Pierluigi Bonomo, Mariangela Sottili, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)Pierluigi Bonomo, Isacco Desideri, Mauro Loi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 9, 2025
Fluorescent Deferoxamine Complexes of Cu(II) and Zr(IV): Insights in the Development of Dual Imaging ProbesAndrea Bencini, Yschtar Tecla Simonini Steiner, Virginia Zizi, et al.
Clinical & Experimental Metastasis|October 15, 2022
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancerGiulio Francolini, Vanessa Di Cataldo, Beatrice Detti, et al.
Tumori|February 8, 2013
From a waiting list to a priority list: a computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for radiotherapySilvia Scoccianti, Benedetta Agresti, Gabriele Simontacchi, et al.
Pageof 9